Introduction

Thyroid hormone plays an important role in thermogenesis, regulation of body temperature and maintenance of metabolic homeostasis. Triiodothyronine (T3) deficiency leads to increased body weight (BW) and cold intolerance (Duntas, 2002), whereas excess T3 causes heat intolerance and weight loss as a result of increased metabolic rate (Moller et al, 1996). T3 acts by binding to nuclear hormone receptors encoded by the TR and TR genes (TR1 and 2, TR1 and 2) (Sap et al, 1986; Weinberger et al, 1986; Koenig et al, 1988). Ligand-bound TRs function as holoreceptors, upregulating target genes that have a positive thyroid hormone response element and downregulating those with a negative one. Importantly, unliganded TRs act as aporeceptors that exert the opposite transcriptional effects, and thereby cause the deleterious effects associated with hypothyroidism.

T3 increases free-fatty acid (FFA) levels by enhancing lipid mobilization, resulting in increased -oxidation. Induction of gluconeogenesis and glycogenolysis by T3 causes increased free-glucose levels and an accelerated insulin-dependent glucose transport into cells (Weinstein et al, 1994; Dimitriadis and Raptis, 2001). T3-bound TRs activate genes such as those for phosphoenolpyruvate carboxykinase (PEPCK), malic enzyme and acetyl CoA carboxylase (ACC) in liver, muscle, as well as in white (WAT) and brown (BAT) adipose tissue, resulting in increased metabolism (Diamant et al, 1972; Loose et al, 1985; Song et al, 1988; Carvalho et al, 1993; Zabrocka et al, 2006). In addition to the direct effects on gene expression in peripheral tissues, thyroid hormone affects sympathoadrenal signaling by increasing tissue responsiveness to catecholamine and decreasing sympathetic activity (Silva, 2006). The interaction between the sympathetic nervous system and thyroid hormone in adaptive thermogenesis shows that intact thyroid hormone signaling is essential for heat production and adrenergic responsiveness in BAT (Silva, 1995). This is reflected by cold or heat intolerance of animals and humans with hypo- or hyperthyroidism, respectively, and hypo- and hyperthermia in extreme forms of hypo- and hyperthyroidism (Cannon and Nedergaard, 2004; Silva, 2006).

Studies of different TR knockout mice and the use of isoform-selective agonists have shown that TR is essential for proper thermogenesis, whereas TR regulates cholesterol metabolism (Wikstrom et al, 1998; Johansson et al, 1999; Ribeiro et al, 2001; Gullberg et al, 2002; Marrif et al, 2005). Mice lacking all T3-binding TRs have slightly decreased body temperature but are still able to increase metabolic rate in response to cold. However, total heat production is insufficient, rendering the mice cold intolerant (Golozoubova et al, 2004). The observed phenotype in these mice is milder than would be expected based on the observations in hypothyroid animals, emphasizing the important role of target gene repression or activation by the aporeceptor in the pathogenesis of hypothyroidism.

The present studies provide insight into the effects of aporeceptors and differentiate between the central and the tissue autonomous effects of a TR1 aporeceptor on lipid and carbohydrate metabolism. For this, we studied mice heterozygous for a dominant-negative TR1 mutation (R384C) that causes a 10-fold reduction in affinity to T3 (TR1+m mice). Reactivation of the mutant TR1 was achieved either by T3 treatment via drinking water, or by additional TR deletion, which causes a 10-fold increase in serum T3 levels (Tinnikov et al, 2002). Suppression of thyroid hormone signaling by the mutant TR1 enhanced basal metabolism by increasing sympathetic outflow, thus causing resistance to obesity and a lean phenotype. Tissue analyses showed that BAT is the tissue targeted by the sympathetic signaling and identified the enzymatic mechanisms responsible for the elevated energy expenditure. The results show that central effects of the unliganded TR1 override peripheral actions of the receptor.

Results

Reduced BW and fat depots in TR1+m mice

To determine if the unliganded TR1 affected metabolism, tissue analyses, gene expression profiling and measurements of oxygen consumption were done. Heterozygous male TR1+m mice (4–7 months old; n=5–6 per group) had a 16% reduction in BW as compared to wild-type (wt) littermate controls (Figure 1A). Analyses of tissues showed that mutant mice had a 51% reduction in their epididymal WAT (eWAT), a 26% reduction in liver and a 33% reduction in interscapular BAT (iBAT) weight. In contrast, soleus and extensor digitorum longus (EDL) weights were normal (Supplementary data 1), as were the adult skeletal dimensions of TR1+m mice (Bassett et al, 2007). This shows that the reduced tissue weights are associated with a lean body mass and not dwarfism.

Histological analyses showed that adipocytes in eWAT and lipid vacuoles in iBAT were smaller in mutant as compared to wt mice (Figure 1B), a striking difference that was exacerbated by a 16-h fast. The WAT capsule surrounding the iBAT showed an increased number of multi-ocular adipocytes in mutant mice, whereas wt animals had large lipid vacuoles (Figure 1B). To determine if the adipose tissue phenotype was caused by aporeceptor activity of the mutant TR1, we studied TR1+m mice also lacking TR. Such TR1+m -- mice have a 10-fold increase in serum thyroid hormone levels that activates the mutant TR1 (Forrest et al, 1996; Tinnikov et al, 2002). Figure 1C shows that, as expected, eWAT and iBAT cell sizes were comparable to that in control animals (TR1++ +-) and that fat cell necrosis was present in both TR1+m -- mice and control animals. In addition, deletion of TR normalized BW. Histological liver analysis showed that mice carrying the TR1 mutation had lower glycogen content in liver, and that this was normalized by the TR-null allele (Figure 1D). The morphological changes in the mutant mice suggested an increased metabolism that could be resolved through reactivation of the mutant TR1 by high levels of thyroid hormone.

To elucidate the cause of the tissue weight differences, we determined the metabolic rate: O₂ consumption was increased by approximately 20% over an 18-h period in the mutant mice (Figure 1E). A control experiment showed that this difference was not due to increased overall locomotor activity (Supplementary data 2). The data thus indicate that the reduction in adipose tissue mass is caused by an increased metabolic rate.

Resistance to diet-induced obesity

Next, we tested if the BW of the mutant mice could be normalized by increasing their caloric intake through a high-fat diet (HFD). A 12-week treatment failed to normalize BW in the mutant mice, despite their increased caloric intake (Figure 2A–C, Supplementary data 3), indicating a resistance to diet-induced obesity. This was further supported by morphological analysis of iBAT, which showed moderate activation in the TR1+m mice, whereas wt mice showed typical signs of inactive tissue such as increased adipocyte size and scattered fat cell necrosis in eWAT.

However, activation of the mutant receptor by treating the adult mice with pharmacological doses of T3 in combination with an HFD caused a rapid increase in BW in TR1+m mice and markedly reduced their resistance to diet-induced obesity (Figure 2A). In an independent experiment, we measured free T3 levels in mice that received T3 via drinking water, which revealed no difference between the groups (wt 61.67.9; TR1+m 68.23.3 pmol/l). The increase in BW upon T3 treatment was paralleled by a partial normalization of caloric intake (Figure 2C). Furthermore, T3 treatment in combination with control diet (CD) normalized white and brown adipocyte morphology in the mutant mice (Figure 2D). We thus conclude that the resistance to diet-induced obesity and in part also the hyperphagia were caused by the unliganded, mutant TR1.

Accelerated glucose and lipid handling

To determine if carbohydrate level balancing also was affected in TR1+m mice, we performed intraperitoneal glucose tolerance tests (ipGTTs). Figure 3A shows an accelerated glucose clearance, while the insulin response was unexpectedly unaltered. HFD treatment increased glucose concentrations in an ipGTT to the level of wt animals on a CD (Figure 3B). Higher substrate utilization was further supported by increased insulin-mediated glucose uptake in isolated soleus and EDL muscles of TR1+m mice (Figure 3C). Under fed conditions, glucose levels were comparable in wt and mutant mice, whereas insulin tended to be lower in mutants (Supplementary data 4). The increased insulin requirement that is associated with high thyroid hormone levels was reflected by a strong elevation in insulin levels in T3-treated wt animals on an HFD, whereas the mutant mice were protected from this effect (Supplementary data 4). These data indicate that the TR1+m mice have enhanced insulin sensitivity that improves glucose handling, which may be related to their reduced body fat.

Serum parameters were analyzed as a first step to identify the cause of the observed metabolic phenotype. The expected decrease in total T3 (TT3) and total T4 (TT4) in response to a 16-h fast was present, although TT3 and TT4 levels upon fasting remained somewhat higher in mutant mice (Figure 4A). Increased lipid utilization in mutant mice was reflected by lower serum FFAs, triglycerides and cholesterol, independent of diet and feeding status (Figure 4B). These differences were effectively normalized by T3 treatment (Figure 4B). -Hydroxybutyrate levels were normal in TR1+m mice, but remained lower upon fasting, a difference that was not ameliorated by T3 treatment (Figure 4B). We conclude that these results reflect an increased energy demand in TR1+m mice.

To identify which tissues contributed to the observed changes in serum parameters, gene expression profiling was performed on eWAT, iBAT, liver and soleus muscle tissues. The results revealed strong induction of genes involved in lipolysis, lipogenesis and glucose handling in eWAT (Figure 5A; Supplementary data 5A and B). The effects were less pronounced in iBAT and liver, and absent in soleus muscle (Figure 5B and C; Supplementary data 5C–H). In eWAT, target gene expression reflected an increase in both lipogenesis and -oxidation: ACC1 and fatty acid synthase (FAS) were induced six-fold and were paralleled by a four-fold induction of ACC2 (Figure 5A). In concordance with this, PGC1 was three-fold and PPAR four-fold increased in TR1+m mice (Figure 5A), whereas no changes were observed in PPAR expression (Supplementary data 5A–H). Similar but less dramatic changes were seen in iBAT and liver (Figure 5B and C). In the liver, we found evidence for increased gluconeogenesis; PEPCK showed a three-fold increase (Figure 5D). GLUT4 was doubled in eWAT, but remained unaffected in iBAT (Figure 5D). A full overview of all genes analyzed and subsequent statistical analyses are available in Supplementary data 5A–H. The differences between adipose tissues and liver may be partially related to local differences in T3 concentrations, since these tissues rely on different T3 sources. eWAT is dependent on circulating T3, whereas in liver a four-fold induction of type I deiodinase (Dio1) mRNA indicated an increase in local T4 to T3 conversion, suggesting higher local T3 concentrations that would allow partial reactivation of the mutant TR1 (Figure 5C). Type II deiodinase (Dio2) mRNA levels in the fed status in iBAT were similar in wt and mutant mice, whereas in the fasted status Dio2 mRNA increased approximately 12-fold in the mutants as compared to four-fold in the wt mice (Figure 5B). Our data indicate that the TR1 aporeceptor affects glucose and lipid handling via distinct mechanisms and that local differences in deiodination may contribute to the differences between tissues.

In view of the substantial differences in tissue weights and morphology, we performed ELISA on serum leptin levels to confirm that altered tissue mRNA levels were reflected in relevant serum changes. We confirmed that TR1+m mice have lower leptin levels, which are consistent with their increased food intake (Figure 5E). Importantly, lipid handling measured in eWAT and iBAT by enzyme activity assays revealed increased ACC activity in both eWAT and iBAT and malonyl CoA decarboxylase (MCD) activity in iBAT (Figure 5F). The increased lipid mobilization was substantiated by the increased -oxidation seen specifically in iBAT of the mutant mice, which indicated that this tissue is responsible for the increased energy demand in TR1+m mice and therefore for their lean phenotype.

Altered sympathetic outflow

Intriguingly, the observed lean phenotype resembles a state of hyper- rather than hypothyroidism. We therefore tested the possibility that increased sympathetic signaling would be overriding the effects of the TR1 aporeceptor at the tissue level. Since iBAT showed the most hallmarks of hypermetabolism, 8-week-old mice were acclimated to 30°C to inhibit sympathetic stimulation of facultative thermogenesis. Figure 6A shows that this resulted in normalized eWAT and iBAT weights in mutant mice, although body and liver weights remained lower. Food intake was decreased below wt levels and O₂ consumption was normalized (Figure 6B). The mutant mice gained weight rapidly (Figure 6C), which was associated with normalization of gene expression levels of ACC, CPT1, PGC1, PPAR and GLUT4 in eWAT (Figure 6D). The adipose tissue morphology of the mutant mice normalized during the acclimation to 30°C (Figure 6E).

To study if the facultative thermogenesis in BAT was responsive to a norepinephrine (NE) challenge, the ability of TR1+m mice to defend their body temperature was tested. Both in a short-term (1.5 h) and long-term (6 h) experiment, TR1+m mice successfully defended their body temperature (Figure 7A and B). However, the mutant mice had a significant increase in their lower critical temperature (LCT) (which is the ambient temperature below which basal metabolic rate becomes insufficient to balance heat loss), and the defended body temperature was higher (37°C versus 36°C in wt), as calculated by extrapolation of the temperature defense curve (Figure 7A). Furthermore, their body temperature, when kept at 21°C, was approximately 1°C lower than normal (37.3°C versus 38.2°C in wt mice; Figure 7B). This contrasts the subsequent iBAT gene expression analysis. The mutant mice that were exposed to cold for 6 h showed reduced UCP1 and PGC1 mRNA levels, whereas Dio2 and mitochondrial transcription factor 1 (TFAM1) were normal (Figure 7C). This demonstrates a minor but significant impairment in iBAT function of TR1+m mice, which is in agreement with their lower body temperature despite the increased calculated theoretical defended body temperature.

BAT sensitivity to -adrenergic receptor-induced thermogenesis was studied by measuring O₂ consumption after injection of NE. We found that the increase in O₂ consumption caused by NE was delayed in TR1+m mice, even though the O₂ consumption during basal thermogenesis and the maximum response to NE were unaltered (Figure 7D, left panel). The NE challenge was subsequently performed in mice acclimated to 30°C to exclude that increased basal sympathetic tone in mutant mice affected the response to acute NE stimulation. Surprisingly, the BAT response to NE was even further impaired in these mutant mice (Figure 7D, right panel). In addition, TR1+m mice acclimated to 30°C showed lower O₂ consumption during basal thermogenesis, which is in agreement with the lower O₂ consumption in TR1+m mice above the LCT. Our data thus indicate that impaired sympathetic signaling in the BAT due to the mutant TR1 is partially compensated through increased basal sympathetic tone.

Discussion

In the present study, we show that, contrary to expectation, the mutant TR1R384C with aporeceptor activity causes hypermetabolism associated with increased O₂ consumption, hyperphagia and resistance to diet-induced obesity. Treatment with thyroid hormone has two effects since the mutant TR1 represses wt TR1 and TR function: (i) reactivation of the mutant TR1 and (ii) restoration of wt TR and TR signaling. Thus, it is unlikely that the normalization, as observed by additional deletion of TR, can be ascribed to the absence of the receptor per se. Rather, the rescue of the metabolic phenotype results from the subsequent 10-fold elevation in thyroid hormone levels. The demonstration that reactivating the aporeceptor with high levels of T3 administered via the drinking water ameliorated the hypermetabolic phenotype in TR1+m mice with intact TR alleles confirms that the phenotype was caused by the unliganded TR1.

The evidence for BAT being the tissue responsible for the high energy expenditure rests on several observations: the histology indicated a metabolic activation, the ACC and MCD expression levels and enzyme assays pointed to prominent activities, and the high -oxidation seen in BAT but not in WAT or liver (unpublished) further supported the concept. The normalization by acclimation to 30°C firmly established BAT as the tissue responsible for the high energy expenditure, and indicates that the mutant TR1 mediates the hypermetabolism by interfering with sympathetic signaling. Thus, our findings suggest that a TR1 aporeceptor acting centrally can predominate over its antagonistic effects in peripheral tissues. It is possible that similar mechanisms of action should be considered when studying the effects of other nuclear hormone receptors on peripheral lipid and glucose metabolism.

The data also allow the interpretation of why the other tissues examined exhibited signs of elevated metabolism. High activity in BAT will first deplete the local energy stores, as was evident in our histological analyses of BAT tissue. Secondarily, lipid stores in WAT will be mobilized, requiring elevated lipogenesis and the type of increases in expression of, for example, ACC1, FAS, LPL and HSL we observed; eventually, WAT content in the animal will decrease. That both the liver and the serum were devoid of or had reduced lipids is likely to be a further consequence of supplying BAT with energy.

The mutant mice also showed an increased glucose tolerance. Muscle had a rapid uptake of glucose, whereas in particular the liver overexpressed genes involved in glucose handling and lacked histological signs of glycogen. Interestingly, the liver weights failed to normalize and the expression of Dio1 remained high after acclimation to 30°C, whereas the lipid and glycogen stores were similar to those of controls (unpublished). An interpretation of this is that carbohydrate stores also become depleted by the metabolically active BAT. However, the failure of the liver to fully normalize indicates either a residual, tissue autonomous effect of the mutant TR1 or that it affects the size of the liver during development.

In a previous report (Tinnikov et al, 2002), we described normal adipose content in 7 to 8-week-old TR1+m mice, which contrasts the results obtained in this study using 4 to 7-month-old animals. The distinct results may be due to the fact that the mutant mice have a delayed postnatal development and reach full maturation 2–4 weeks later than wt controls, but may also reflect genotype-specific changes in metabolism that occur during aging. The developmental delay affects, for example, weight gain, bone mineralization, eye opening (Tinnikov et al, 2002) as well as brain maturation (K Wallis, M Sjögren and B Vennström, unpublished data). It is thus possible that the defective neuronal development also contributes to aberrant central signaling and subsequent hypermetabolism.

Hypermetabolism in TR1 mice: the result of increased sympathetic signaling

Obligatory thermogenesis is sufficient to sustain core temperature over a limited range of environmental temperatures, below which facultative thermogenesis is required to stay warm. Hence, cold exposure elicits a complex response marked by increases in thermogenic capacity of BAT, oxygen consumption and food intake. The thermogenic response in BAT is induced by sympathetic stimulation resulting in NE release, which acts synergistically with T3 (Silva, 2006). Increased sympathetic activity causes increased local T3 concentrations via induction of Dio2, brown adipocyte proliferation, increased UCP1 expression and activity and mitochondrial biogenesis, a process known as recruitment (Cannon and Nedergaard, 2004). Morphological analyses of adipose tissues of TR1+m mice indicated interconversion of WAT into BAT, which was in accordance with BAT activation reflected by increased PGC1, LPL and Dio2 mRNA expression upon fasting. However, there were no differences in UCP1 expression, or in TFAM or NRF1, which are involved in mitochondrial biogenesis. These data are in line with observations in mice lacking all thyroid hormone receptors that are able to recruit BAT and have normal UCP1 expression (Golozoubova et al, 2004).

Fatty acid synthesis and oxidation occur in separate cell compartments to prevent immediate oxidation of newly synthesized fatty acids. ACC1 converts acetyl CoA into a malonyl CoA pool, which serves as a substrate for fatty acid elongation by FAS, whereas the malonyl CoA produced by ACC2 serves as a potent inhibitor of CPT1 and thus of -oxidation (Abu-Elheiga et al, 2001). Upregulation of both fatty acid synthesis and -oxidation is stimulated by sympathetic signaling and occurs during cold exposure, when fatty acid synthesis secures fat stores to provide fuel for heating the body during continued periods of increased -oxidation. The underlying mechanism may be explained by distinct intracellular malonyl CoA pools and selective increased malonyl CoA turnover caused by increased MCD activity, resulting in increased CPT1 activity (Yu et al, 2002). The increased levels of ACC1, ACC2 and FAS mRNA and increased MCD activity and -oxidation in TR1+m mice are in accordance with such a state of increased sympathetic signaling.

At thermoneutrality, when obligatory thermogenesis is able to meet the body requirements to maintain body temperature, TR1+m mice have a lower metabolic rate (Figure 7), which is congruent with a receptor-mediated hypothyroidism. However, at lower ambient temperatures, TR1+m mice had an increased metabolic rate, which necessitated a study of their thermoregulation. Previously, TR isoform-specific actions were identified in facultative thermogenesis: transcriptional induction of UCP1 requires TR, whereas TR is essential for the synergistic effect between sympathetic signaling and thyroid hormone action (Ribeiro et al, 2001). Upon a 6-h cold exposure, the TR1+m mice failed to increase UCP1 and PGC1 expression levels to the same extent as wt mice. This may be due to interference by the mutant TR1 with TR function in BAT. The ability of TR1+m mice to successfully defend their body temperature, despite impaired UCP1 stimulation, indicates that the TR1+m mice rely in part on different mechanisms to maintain body temperature, possibly shivering thermogenesis.

The defective sympathetic stimulation of facultative thermogenesis observed in hypothyroid mice (Ribeiro et al, 2001) was also present in TR1+m mice, as was reflected by their delayed increase in O₂ consumption in response to an NE challenge. The O₂ response was even further impaired in mice acclimated to 30°C, suggesting that increased sympathetic outflow at 21°C is part of a compensatory mechanism to keep body temperature sufficiently high. In addition, the lower body temperature observed at 21°C was in contrast with the higher theoretical defended body temperature. This discrepancy suggests that facultative thermogenesis is unable to produce enough heat through uncoupling to reach the defended body temperature. This is likely caused by a BAT-specific effect of the mutant TR1, causing increased hypothalamic outflow that would stimulate thermogenesis through alternative mechanisms and causing energy expenditure through a futile cycle.

Metabolic characteristics of TR1-mediated resistance to thyroid hormone

More than 300 patient families with resistance to thyroid hormone syndrome, RTH, have been found. The patients have an inherited mutation in the TR gene (Weiss and Refetoff, 1996, 2000). However, no patients harboring an equivalent mutation in the TR gene have been described. This may be related to the absence of obvious aberrancies in thyroid hormone levels, unlike those found in the RTH patients.

Based on the results presented here, a hypothesis regarding the metabolic characteristics of patients with a TR1 mutation indicates hypermetabolism. However, the phenotypes of two other mouse strains with mutant TR1 genes differ from what is described here: dwarfism accompanied by reduction in WAT by the TR1PV allele (Liu et al, 2003; Ying et al, 2007), or obesity in combination with impaired catecholamine-stimulated lipolysis by the TR1P398H mutant (Liu et al, 2003; Ying et al, 2007). In cultured WAT cells, the TR1PV mutant was described to repress the ability of PPAR to activate its target genes, and the expression of ACC, FAS and PPAR was found to be reduced in the mutant animals, in contrast to what was seen with the TR1R384C allele in our study. The TR1P398H mutation strongly inhibits liver PPAR expression and reduces expression of genes involved in fatty acid oxidation by interfering with PPAR action (Liu et al, 2007), whereas TR1R384C mutation led to a strong induction of PPAR gene expression, no change in PPAR levels and overexpression of genes involved in lipid handling. Taken together, this indicates that the position of a mutation may determine how the mutant receptor interacts with different hormonal response elements, other nuclear receptors and/or their coregulators.

Nevertheless, our results as well as those by Liu et al (2007) support the concept that the TR1R384C receptor is akin to a wt aporeceptor: it confers on the CPT1 and ACO response elements the same moderate PPAR-interfering properties as wt TR1 (Liu et al, 2007), and its activation by high levels of T3 leads to normalization of the hypermetabolism as well as most other phenotypic aberrancies (Tinnikov et al, 2002; Venero et al, 2005; Bassett et al, 2007). The normalization of metabolism by acclimation to 30°C furthermore argues against mechanisms involving, for example, constitutive binding by TR1R384C to the coactivator PCG1 or the corepressor RIP140, events that could lead to a phenotype very similar to the one we have described.

Hypothalamic signaling

The dramatic improvement of the metabolic phenotype by functional denervation of sympathetic signaling to the BAT points to the importance of the hypothalamus in regulating metabolic rate and the ability of central signaling to override peripheral effects. Intriguingly, increased sympathetic outflow resembles a state of hyperthyroidism, rather than of hypothyroidism. Discrepancies between peripheral and central thyroid hormone signaling have also been reported during critical illness in humans and fasting in rodents (Lechan and Fekete, 2004, 2006; Fliers et al, 2006). During severe illness, thyroid hormone levels decrease without giving rise to high levels of TSH or TRH, and the effects are mediated by the hypothalamus (Fliers et al, 1997; Wiersinga, 2000). During fasting and in experimental models of critical illness, a relative state of hyperthyroidism is present in the hypothalamus as a result of increased local deiodination (Diano et al, 1998; Boelen et al, 2004; Fekete et al, 2004; Coppola et al, 2005). It is feasible that the mutant TR1 is involved in regulating hypothalamic T3 levels under these conditions and thereby affects sympathetic outflow to BAT and thus could contribute to the hypermetabolic phenotype. The possibility that altered hypothalamic signaling also can contribute to metabolic wasting, such as that observed in cancer cachexia, merits further study.

Materials and methods

Animals

The mouse strain carrying the dominant-negative R384C mutation in TR1 and the combination with a TR-null allele have been described previously (Tinnikov et al, 2002).

The TR1R384C mice used in the experiments here had been backcrossed to C57BL/6NCrl for 3–4 or 8–10 generations. Experiments done in both cohorts produced similar results. Littermate male mutant and wt mice aged 4–7 months were kept at 21°C on a 12 h light/12 h dark cycle. For thermoneutrality studies, mice were transferred to 30°C at the age of 2 months and kept at this temperature for at least 4 weeks. Control and HFD mice were obtained from Research Diets (New Brunswick, NJ) (D12450B: 3.85 kcal/g, 10% kcal fat; D12451: 4.73 kcal/g, 45% kcal fat). Animal care procedures were in accordance with the guidelines set by the European Community Council Directives (86/609/EEC). Required animal permissions were obtained from the local ethical committees.

Thyroid hormone treatment and serum parameter measurements

For determination of serum parameters, fed or overnight fasted (16 h) animals were killed by decapitation (after 11 weeks on diet, when applicable), after which trunk blood was collected and tissues dissected for further analyses. Serum was obtained after centrifugation of blood samples and stored at -80°C until assayed for serum parameters.

Animals were placed on control or HFD, and BW and food intake were determined weekly. Animals received T3 for 12 days via drinking water (0.01% albumin, T3 concentration 0.5 g/ml). TT3 and TT4 were measured by radioimmuno assay (TKT31 and TKT41; Diagnostic Products Corporation, Los Angeles, CA). FFA, triglycerides, cholesterol, -hydroxybutyrate and insulin were assayed according to the manufacturer's instructions (FFA: Wako Chemicals GmbH, Neuss, Germany; triglycerides: Sigma Diagnostics Inc., St Louis, MO; cholesterol and -hydroxybutyrate: STANBIO Laboratory, Boerne, TX; insulin: Mercodia AB, Uppsala, Sweden).

Oxygen consumption and thermoregulatory metabolism

O₂ consumption was measured using the Oxymax System (Columbus Instruments, Columbus, OH) or the Somedic Inca System (Somedic Sales AB, Hörby, Sweden). To determine the thermoregulatory metabolism in the mutant TR1 mice, O₂ consumption was studied as a function of ambient temperature. Measurements were performed at temperatures ranging between 7 and 34°C during a 1.5-h period. Metabolic rates at the different temperatures were defined as the lowest, stable metabolic rate observed for at least 4 min. A minimum interval of 3 days was present between measurements at different temperatures. For the NE challenge studies, mice were anesthetized with sodium pentobarbital (70 mg/kg BW) and injected with (NE 1 mg/kg BW). Defense of body temperature over a 6-h period was tested by measurements using a rectal probe with a 1-h interval (n=6 mice per group).

Glucose handling

2-Deoxyglucose uptake was measured on isolated EDL (fast-twitch glycolytic) and soleus (slow-twitch oxidative) muscles as described elsewhere (Shashkin et al, 1995). For ipGTT, glucose was injected (2 g/kg BW: 20% solution) after a 16-h fast. For determination of glucose levels, blood samples were obtained from the tail at 0, 15, 30, 60 and 120 min after injection and analyzed using an Accu-Check Sensor glucose meter (Roche Diagnostics). For insulin levels, blood samples were taken at 0, 30, 60 and 120 min after glucose injection.

Histology

Tissues were fixed in 10% formalin rinsed in PBS, dehydrated through increasing concentrations of ethanol, cleared and embedded in paraffin, sectioned and stained with hematoxylin and eosin (H&E). To demonstrate intracellular lipids, formalin-fixed tissue was cryoprotected with sucrose, and frozen sections were stained with Oil Red O.

Real-time PCR

RNA was isolated from snap-frozen tissues using an RNeasy mini kit or RNeasy lipid kit (Qiagen, Sweden) according to the manufacturer's instructions. cDNA was obtained after reverse transcription and used for real-time PCR using the ABI 7300 system and the ABI Prism 7000 (Applied Biosystems, Sweden). Quantification was performed using a standard curve and HPRT was used as a reference gene. Primer sequences are listed in Supplementary data 6.

-Oxidation and enzyme activity assays

Fat tissue (eWAT and iBAT) was incubated in low-glucose DMEM (Gibco, Sweden) containing 2% (w/v) fatty acid-free BSA, 0.30 mM L-carnitine and ³H-palmitic acid (3 Ci per well). Excess palmitic acid was removed by trichloroacetic acid precipitation. After extraction with chloroform/methanol (2:1), ³H₂O production was determined (Wang et al, 2003). ACC activity was determined by an NADH-coupled assay and normalized to protein content (Wagner et al, 1998). Background phosphatase activity was determined in samples without acetyl CoA and used for correction. MCD activity was determined using a carnitine acetyltransferase-linked assay (Antinozzi et al, 1998).

Statistical analysis

Prism 4 for Macintosh and In Stat 3 for Macintosh software was used for statistical analysis. Data were analyzed using the Student's t-test or two-way ANOVA followed by a Bonferroni or Tukey test to compare between groups. Differences were considered significant if P<0.05. All data are represented as their mean values.e.m.

Supplementary data

Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).

Acknowledgements

We are grateful to Drs Barbara Cannon, Jan Nedergaard and Juleen Zierath for constructive discussions. We also thank the core facilities at Karolinska Institutet for physiological and histological analyses. This project was financially supported by the Swedish Cancer Society, The Swedish Research Council, The Swedish Diabetes Foundation, The Wallenberg Foundations, The Netherlands Organization for Scientific Research and The Niels Stensen Foundation.

References

Abu-Elheiga L, Matzuk MM, Abo-Hashema KA, Wakil SJ (2001) Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 291: 2613–2616 | Article | PubMed | ISI | ChemPort |

Antinozzi PA, Segall L, Prentki M, McGarry JD, Newgard CB (1998) Molecular or pharmacologic perturbation of the link between glucose and lipid metabolism is without effect on glucose-stimulated insulin secretion. A re-evaluation of the long-chain acyl-CoA hypothesis. J Biol Chem 273: 16146–16154 | Article | PubMed | ISI | ChemPort |

Bassett JH, Nordstrom K, Boyde A, Howell PG, Kelly S, Vennstrom B, Williams GR (2007) Thyroid status during skeletal development determines adult bone structure and mineralization. Mol Endocrinol 21: 1893–1904 | Article | PubMed | ISI | ChemPort |

Boelen A, Kwakkel J, Thijssen-Timmer DC, Alkemade A, Fliers E, Wiersinga WM (2004) Simultaneous changes in central and peripheral components of the hypothalamus–pituitary–thyroid axis in lipopolysaccharide-induced acute illness in mice. J Endocrinol 182: 315–323 | Article | PubMed | ISI | ChemPort |

Cannon B, Nedergaard J (2004) Brown adipose tissue: function and physiological significance. Physiol Rev 84: 277–359 | Article | PubMed | ISI | ChemPort |

Carvalho SD, Negrao N, Bianco AC (1993) Hormonal regulation of malic enzyme and glucose-6-phosphate dehydrogenase in brown adipose tissue. Am J Physiol 264: E874–E881 | PubMed | ISI | ChemPort |

Coppola A, Hughes J, Esposito E, Schiavo L, Meli R, Diano S (2005) Suppression of hypothalamic deiodinase type II activity blunts TRH mRNA decline during fasting. FEBS Lett 146: 4654–4658 | Article |

Diamant S, Gorin E, Shafrir E (1972) Enzyme activities related to fatty-acid synthesis in liver and adipose tissue of rats treated with triiodothyronine. Eur J Biochem 26: 553–559 | Article | PubMed | ISI | ChemPort |

Diano S, Naftolin F, Goglia F, Horvath TL (1998) Fasting-induced increase in type II iodothyronine deiodinase activity and messenger ribonucleic acid levels is not reversed by thyroxine in the rat hypothalamus. Endocrinology 139: 2879–2884 | Article | PubMed | ISI | ChemPort |

Dimitriadis GD, Raptis SA (2001) Thyroid hormone excess and glucose intolerance. Exp Clin Endocrinol Diabetes 109 (Suppl 2): S225–S239 | Article |

Duntas LH (2002) Thyroid disease and lipids. Thyroid 12: 287–293 | Article | PubMed | ISI | ChemPort |

Fekete C, Gereben B, Doleschall M, Harney JW, Dora JM, Bianco AC, Sarkar S, Liposits Z, Rand W, Emerson C, Kacskovics I, Larsen PR, Lechan RM (2004) Lipopolysaccharide induces type 2 iodothyronine deiodinase in the mediobasal hypothalamus: implications for the nonthyroidal illness syndrome. Endocrinology 145: 1649–1655 | PubMed | ISI | ChemPort |

Fliers E, Alkemade A, Wiersinga WM, Swaab DF (2006) Hypothalamic thyroid hormone feedback in health and disease. Prog Brain Res 153: 189–207 | PubMed | ISI | ChemPort |

Fliers E, Guldenaar SE, Wiersinga WM, Swaab DF (1997) Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. J Clin Endocrinol Metab 82: 4032–4036 | Article | PubMed | ISI | ChemPort |

Forrest D, Erway LC, Ng L, Altschuler R, Curran T (1996) Thyroid hormone receptor beta is essential for development of auditory function. Nat Genet 13: 354–357 | Article | PubMed | ISI | ChemPort |

Golozoubova V, Gullberg H, Matthias A, Cannon B, Vennstrom B, Nedergaard J (2004) Depressed thermogenesis but competent brown adipose tissue recruitment in mice devoid of all hormone-binding thyroid hormone receptors. Mol Endocrinol 18: 384–401 | PubMed | ISI | ChemPort |

Gullberg H, Rudling M, Salto C, Forrest D, Angelin B, Vennstrom B (2002) Requirement for thyroid hormone receptor beta in T3 regulation of cholesterol metabolism in mice. Mol Endocrinol 16: 1767–1777 | Article | PubMed | ISI | ChemPort |

Johansson C, Gothe S, Forrest D, Vennstrom B, Thoren P (1999) Cardiovascular phenotype and temperature control in mice lacking thyroid hormone receptor-beta or both alpha1 and beta. Am J Physiol 276: H2006–H2012 | PubMed | ISI | ChemPort |

Koenig RJ, Warne RL, Brent GA, Harney JW, Larsen PR, Moore DD (1988) Isolation of a cDNA clone encoding a biologically active thyroid hormone receptor. Proc Natl Acad Sci USA 85: 5031–5035 | Article | PubMed | ChemPort |

Lechan RM, Fekete C (2004) Feedback regulation of thyrotropin-releasing hormone (TRH): mechanisms for the non-thyroidal illness syndrome. J Endocrinol Invest 27 (Suppl): 105–119

Lechan RM, Fekete C (2006) The TRH neuron: a hypothalamic integrator of energy metabolism. Prog Brain Res 153: 209–235 | PubMed | ISI | ChemPort |

Liu YY, Heymann RS, Moatamed F, Schultz JJ, Sobel D, Brent GA (2007) A mutant thyroid hormone receptor alpha antagonizes peroxisome proliferator-activated receptor alpha signaling in vivo and impairs fatty acid oxidation. Endocrinology 148: 1206–1217 | PubMed | ISI | ChemPort |

Liu YY, Schultz JJ, Brent GA (2003) A thyroid hormone receptor alpha gene mutation (P398H) is associated with visceral adiposity and impaired catecholamine-stimulated lipolysis in mice. J Biol Chem 278: 38913–38920 | Article | PubMed | ISI | ChemPort |

Loose DS, Cameron DK, Short HP, Hanson RW (1985) Thyroid hormone regulates transcription of the gene for cytosolic phosphoenolpyruvate carboxykinase (GTP) in rat liver. Biochemistry 24: 4509–4512 | Article | PubMed | ISI | ChemPort |

Marrif H, Schifman A, Stepanyan Z, Gillis MA, Calderone A, Weiss RE, Samarut J, Silva JE (2005) Temperature homeostasis in transgenic mice lacking thyroid hormone receptor-alpha gene products. Endocrinology 146: 2872–2884 | Article | PubMed | ISI | ChemPort |

Moller N, Nielsen S, Nyholm B, Porksen N, Alberti KG, Weeke J (1996) Glucose turnover, fuel oxidation and forearm substrate exchange in patients with thyrotoxicosis before and after medical treatment. Clin Endocrinol (Oxf) 44: 453–459 | Article | PubMed | ChemPort |

Ribeiro MO, Carvalho SD, Schultz JJ, Chiellini G, Scanlan TS, Bianco AC, Brent GA (2001) Thyroid hormone–sympathetic interaction and adaptive thermogenesis are thyroid hormone receptor isoform-specific. J Clin Invest 108: 97–105 | Article | PubMed | ISI | ChemPort |

Sap J, Munoz A, Damm K, Goldberg Y, Ghysdael J, Leutz A, Beug H, Vennstrom B (1986) The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature 324: 635–640 | Article | PubMed | ISI | ChemPort |

Shashkin P, Koshkin A, Langley D, Ren JM, Westerblad H, Katz A (1995) Effects of CGS 9343B (a putative calmodulin antagonist) on isolated skeletal muscle. Dissociation of signaling pathways for insulin-mediated activation of glycogen synthase and hexose transport. J Biol Chem 270: 25613–25618 | PubMed | ISI | ChemPort |

Silva JE (1995) Thyroid hormone control of thermogenesis and ener